Sleep Disorder Clinical Trial
Official title:
Effects of Nocturnal Hypertension on Sleep Quality in Renal Transplant Recipients
Nocturnal hypertension (i.e. blood pressure values >120/70 or 10% higher than diurnal values, as measured by ambulatory blood pressure monitoring, ABPM) is particularly frequent in renal transplant recipients (RTR), despite the use of antihypertensive drugs. Since RTR are also affected by several sleep disorders (like insomnia, restless legs syndrome, sleep apnoea) that frankly impair their quality of sleep (SQ), the aim of the present study is to ascertain whether a relationship exists between nocturnal hypertension and SQ. In fact, both nocturnal hypertension and sleep disorders may favour the onset or the progression of cardiovascular diseases, the first cause of death in RTR.
Hypertension affects the great majority of renal transplant recipients (RTR) and its
persistence may negatively influence the outcome of the graft. Unfortunately, its diagnosis
is not univocal since office measurement of blood pressure (BP) may reveal a "white coat
hypertension" in normotensive subjects, or might not detect hypertension if pills are taken
immediately before BP control. Therefore for a correct diagnosis the use of ambulatory BP
monitoring (ABPM) is strongly advised. Recent studies employing this methodology have shown
that the prevalence of nocturnal hypertension (i.e. blood pressure values >120/70 or 10%
higher than diurnal values) affects a great number of renal transplant recipients (RTR), even
despite the use of antihypertensive drugs ("non-dipper" patients). It is well known that
nocturnal hypertension enhances the development of cardiovascular diseases, but it is not
clear whether (and to what extent) it also affects the quality of sleep of these patients.
Sleep disturbances like insomnia, restless legs syndrome and sleep apnoea, in fact, are
particularly common in RTR, despite these patients report significantly better quality of
life compared to patients with chronic renal failure under conservative or dialysis
treatment. The working hypothesis of the present study is to evaluate whether any
relationship exists between nocturnal hypertension and sleep quality, since also sleep
disorders may favour the onet and the progression of cardiovascular diseases, the first cause
of death in RTR with functioning graft.
The study will be carried out on all the available RTR in regular follow-up at the DH of
Nephrology and Renal Transplantation of the University Federico II of Naples (Italy).
Inclusion criteria are: age >18 years, renal transplant vintage >1 year, stable renal
function in the last 6 month, no change in immunosuppressive nor antihypertensive treatment
in the last 3 months, no intercurrent infection in the last 3 months. Twenty-four hour ABPM
will be performed during the regular follow-up of patients in the investigator's Unit.
Hypertension will be diagnosed when the patient takes antihypertensive drugs or when his . BP
is >130/80 mmHg (24-hour average value), or >135/85 (average values of daily BP) or >120/70
(average values of nocturnal BP). The patient will be considered "non-dipper" when the ratio
Systolic nocturnal BP/Systolic diurnal BP is >0.9.
Sleep quality will be evaluated through a validated version of the Pittsburgh Sleep
Questionnaire a self-rated questionnaire, consisting of 19 questions which assess a wide
variety of factors relating to sleep quality, including estimates of sleep duration and
latency and of frequency and severity of specific sleep-related problems. These 19 items are
grouped into seven-component scores, each weighted equally on a 0-3 scale. The seven
components are then summed to yield a global index (PSQI) ranging between 0 and 21; higher
scores indicate a worse sleep quality (>5, poor sleepers; <5, good sleepers). The seven
components of the PSQI are subjective sleep quality, sleep latency, sleep duration, habitual
sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction.
The relationship between nocturnal hypertension and sleep quality will be evaluated either by
bivariate analysis and by multiple linear regression analyses. In the multivariate model, all
the variables associated to an elevated night/day systolic pressure ratio will be considered
if the P value is 0.10 or less at bivariate analysis. The relationship between increased
night/day SBP ratio and increased PSQI will be also investigated by multivariate logistic
regression model.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Recruiting |
NCT04786314 -
The Effect of Hot and Cold Water Application on Pregnant Women With Restless Leg Syndrome
|
N/A | |
Recruiting |
NCT05775731 -
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
|
||
Recruiting |
NCT03326765 -
Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)
|
N/A | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Completed |
NCT03903263 -
Sleep Disturbances in Dermatology Patients
|
||
Not yet recruiting |
NCT06012513 -
Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis
|
||
Not yet recruiting |
NCT05950932 -
Effects of Melissa Extract on Sleep Characteristics
|
Phase 4 | |
Completed |
NCT01463839 -
Sleep Disorder and Oral Habits in Children
|
N/A | |
Completed |
NCT00940589 -
Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor
|
Phase 2 | |
Recruiting |
NCT06093633 -
A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders
|
||
Completed |
NCT06108115 -
Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder
|
N/A | |
Completed |
NCT05511818 -
Radicle Rest: A Study of Cannabinoids on Sleep and Health Outcomes
|
N/A | |
Active, not recruiting |
NCT04291014 -
Light Therapy for PD - Dose Selection
|
N/A | |
Completed |
NCT04560595 -
Remote Guided Caffeine Reduction
|
N/A | |
Completed |
NCT06008470 -
Investigation of Respiratory Muscle Strength, Exercise Capacity, Physical Activity and Sleep Quality Level in Individuals With Covid-19 Infection
|
||
Recruiting |
NCT06129942 -
Light Therapy in Parkinson's Disease
|
N/A | |
Recruiting |
NCT04318067 -
Melatonin in ADHD and Sleep Problems
|
Phase 4 | |
Completed |
NCT03532269 -
Validation of the Sleep Assessment Algorithm in the Medical Application Nightly
|
N/A | |
Completed |
NCT03857802 -
Efficiency of a Nursing Intervention in Sleep Hygiene
|
N/A |